Pricing and market access professional with 21 years experience in the pharmaceutical industry, including 5 years in operational management of market access teams, and 4 years in the field. Currently leading the access function with >100 associates in a diverse region including China and a diverse product portfolio. In leadership teams, he always strives to influence beyond his function to boost performance, foster innovation and improve team culture.

Specialties:
- Leading teams to fulfil their full potential via innovative solutions
- Developing value propositions through customer insight
- Pharma pricing, from strategy through to implementation
- Cross-functional collaboration to bring pricing & access into the heart of business strategy
- Role of real world (observational) evidence in value propositions
- Shaping early products development to maximize product value, especially multiple indication products
- Launch excellence, from a global, regional and country perspective
- Managing culturally diverse, remote teams in volatile environments
- Maximizing the value of diverse product portfolios

Therapy area expertise in oncology, cardiovascular, immunology & dermatology, neuroscience, ophthalmology, orphan drugs.

Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 1 billion people globally and we are finding innovative ways to expand access to our latest treatments. About 125 000 people of more than 140 nationalities work at Novartis around the world.